Compare
Johnson & Johnson vs Viatris (JNJ vs VTRS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Viatris (VTRS) +85.2%; so far this year the figures are +33.5% and +59.9%.
Johnson & Johnson is the larger company by market value, about 29.1 times the size of Viatris.
Revenue grew +7.8% at JNJ and +4.3% at VTRS over the last year.
JNJ yields 1.91%. VTRS yields 2.41%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | VTRS | |
|---|---|---|
| Price | $276.22 | $19.91 |
| 1-day | +1.43% | +4.96% |
| YTD | +33.47% | +59.92% |
| 1 year | +48.51% | +85.21% |
| 3 years | +85.77% | +123.21% |
| Market cap | $665.0B | $22.8B |
| P/E | 41.9 | — |
| P/S | 6.69 | 1.55 |
| P/B | 8.16 | 1.67 |
| Revenue growth | +7.80% | +4.30% |
| EPS growth | -36.40% | — |
| Gross margin % | 67.6 | 35.4 |
| Net margin % | 16.2 | -23.9 |
| ROE % | 19.7 | -25.7 |
| Debt / equity | 0.55 | 0.97 |
| FCF yield % | 3.1 | 9.2 |
| Dividend yield % | 1.91 | 2.41 |
| Beta | -0.09 | 0.67 |
| RSI (14) | 59.4 | 68.1 |
| Technical rating |